Loading
Life sciences · Journal article
The Nurse Practitioner · September 24, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
ABSTRACT: Group A Streptococcus (GAS) pharyngitis remains the leading bacterial cause of acute sore throat worldwide. Surges in GAS infections are driven by hypervirulent strains such as M1UK. The 2025 clinical practice guideline update from the Infectious Diseases Society of America introduces evidence-based recommendations for risk assessment using clinical scoring systems to optimize diagnostic testing and reduce unnecessary antibiotic use. This review examines current diagnostic approaches, treatment protocols, antimicrobial resistance patterns, and emerging therapeutic strategies to support nurse practitioners in delivering evidence-based, stewardship-aligned patient care.